These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33081805)

  • 1. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Kohler JC; Bowra A
    Global Health; 2020 Oct; 16(1):101. PubMed ID: 33081805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploration of anti-corruption and health in international organizations.
    Bowra A; Saeed G; Gorodensky A; Kohler JC
    PLoS One; 2022; 17(8):e0269203. PubMed ID: 35917329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global Fund: why anti-corruption, transparency and accountability matter.
    Chang Z; Rusu V; Kohler JC
    Global Health; 2021 Sep; 17(1):108. PubMed ID: 34537059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 8. Governance and Health Aid from the Global Fund: Effects Beyond Fighting Disease.
    Kavanagh MM; Chen L
    Ann Glob Health; 2019 May; 85(1):. PubMed ID: 31099506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews.
    Gorodensky A; Grundy Q; Persaud N; Kohler JC
    J Glob Health; 2023 Dec; 13():04165. PubMed ID: 38063440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to reduce corruption in the health sector.
    Gaitonde R; Oxman AD; Okebukola PO; Rada G
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008856. PubMed ID: 27528494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 12. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
    Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
    Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Clinton C; Sridhar D
    Lancet; 2017 Jul; 390(10091):324-332. PubMed ID: 28139255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A concept in flux: questioning accountability in the context of global health cooperation.
    Bruen C; Brugha R; Kageni A; Wafula F
    Global Health; 2014 Dec; 10():73. PubMed ID: 25487705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 17. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
    Griffore KA; Bowra A; Guilcher SJT; Kohler J
    Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.